【序号】：1 【作者】：Mazzei T1, Mini E, Eandi M, Reali EF, Fioretto L, Bartoletti R, Rizzo M, Calabrò G, Periti P. 【题名】：Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation. 【期刊】：Drugs Exp Clin Res. 1 【年、卷、期、起止页码】:1989;15(8):373-87. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/2513176 【序号】：2 【作者】：Niijima T1, Aso Y, Akaza H, Fujita K, Fuse H, Hosaka M, Isurugi K, Kamidono S, Katayama T, Kawabe K, et al. 【题名】：[Clinical phase I and phase II study on a sustained release formulation of leuprorelin acetate (TAP-144-SR), an LH-RH agonist, in patients with prostatic carcinoma. Collaborative++ Studies on Prostatic Carcinoma by the Study Group for TAP-144-SR]. 【期刊】：Hinyokika Kiyo. 【年、卷、期、起止页码】:1990 Nov;36(11):1343-60. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/2126912 【序号】：3 【作者】：Okada H1, Heya T, Ogawa Y, Shimamoto T. 【题名】：One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats. 【期刊】：J Pharmacol Exp Ther. 【年、卷、期、起止页码】:1988 Feb;244(2):744-50. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/3126294 【序号】：4 【作者】：Taguchi T1, Koyama H, Yayoi K, Wada T, Takatsuka Y, Sonoo H, Morimoto K, Tominaga T, Abe R, Enomoto K, et al. 【题名】：[Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group]. 【期刊】：Gan To Kagaku Ryoho. 【年、卷、期、起止页码】:1995 Mar;22(4):495-508. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/7887641
应助达人
迎国庆送壕礼！十月发帖抢大疆云台
【官方邀请】高效液相色谱使用情况有奖调研
喜迎国庆！第十七届原创大赛超级原创日参赛奖励翻倍
丹纳赫四十周年寄语征集领大礼包
